Minor
REGENERATE-PD · AAV2-GDNF · Moderate Parkinson's Disease (REGENERATE-PD)
Enrollment closed, study ongoing
AskBio IncPhase 2 NCT06285643 Registry history of NCT06285643 on ClinicalTrials.gov (opens the registry)
Updated
6 active trials 1 recruiting 2 disease areas 1 changes in 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Enrollment closed, study ongoing
AskBio IncPhase 2 NCT06285643 Registry history of NCT06285643 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1/2 | 2 | |
| Phase 2 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06285643 | A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) | Parkinson Disease | Active, Not Recruiting | 2026-10-01 |
| NCT07215403 | Prescriptive Infusion Algorithm (PIA) | PARKINSON DISEASE (Disorder) | Not Yet Recruiting | 2026-07-27 |
| NCT05598333 | Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA… | Congestive Heart Failure | Active, Not Recruiting | 2025-12-03 |
| Phase 1/2 | ||||
| NCT07282847 | A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene)… | Pompe Disease (Late-onset) | Recruiting | 2026-07-20 |
| NCT05230459 | A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic… | Limb Girdle Muscular Dystrophy | Active, Not Recruiting | 2026-08-26 |
| Not specified | ||||
| NCT07081841 | AB-1005 Long-Term Follow-up Study | Parkinson's Disease | Enrolling by Invitation | 2025-10-02 |
Parkinson's Disease (3) · Heart Failure (1)